Hepatitis B surface antigen (HBsAg) prevalence (%) in Kiribati
Kiribati: Hepatitis B surface antigen (HBsAg) prevalence was 0.9% in 2024. ▼ Falling
Latest (2024)
0.9%
Change on year
unchanged
World rank
36th
of 194 countries
All-time high
2.0%
in 2015
All-time low
0.9%
in 2023
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Kiribati, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Kiribati is 0.9%, measured in 2024. That is the lowest value across all 10 years on record.
That represents a change of down 55.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Kiribati peaked at 2.0% in 2015 and was at its lowest, 0.9%, in 2023.
Kiribati ranks 36th of 194 countries on this measure, in the top quarter.
Hepatitis B surface antigen (HBsAg) prevalence in Kiribati, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 2.0% | — |
| 2016 | 2.0% | +0.0% |
| 2017 | 1.9% | -5.0% |
| 2018 | 1.8% | -5.3% |
| 2019 | 1.7% | -5.6% |
| 2020 | 1.4% | -17.6% |
| 2021 | 1.3% | -7.1% |
| 2022 | 1.0% | -23.1% |
| 2023 | 0.9% | -10.0% |
| 2024 | 0.9% | +0.0% |
Kiribati compared with similar countries
- Kiribati's 0.9% is above the median for lower middle income countries, which is 0.6%, 1.5× the median. (47 countries reporting)
- Kiribati's 0.9% is above the median for East Asia & Pacific, which is 0.6%, 1.5× the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.9% | 1.7% | 2.0% | 5 |
| 2020s | 1.1% | 0.9% | 1.4% | 5 |
Countries ranked near Kiribati
- 36 Vietnam 0.9% compare
- 36 Marshall Islands 0.9% compare
- 39 Sao Tome and Principe 0.8% compare
- 39 Seychelles 0.8% compare
- 39 Mauritius 0.8% compare
- 39 Philippines 0.8% compare
More health data for Kiribati
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7209 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,076 deaths per 1,000 people (2090)
- Number of infants who die before age 1 34 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.3672 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0576 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3464 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Kiribati?
- Hepatitis b surface antigen (hbsag) prevalence in Kiribati was 0.9% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Kiribati?
- The highest recorded value was 2.0% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Kiribati?
- The lowest recorded value was 0.9% in 2023.
- How does Kiribati rank for hepatitis b surface antigen (hbsag) prevalence?
- Kiribati ranks 36th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Kiribati?
- Over the last ten years it is down 55.0%. The long-run trend across the full record is falling.
- Where does this Kiribati data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).